|
|
| | Alectinib M4 metabolite Basic information |
| Product Name: | Alectinib M4 metabolite | | Synonyms: | Alectinib M4 metabolite;Alectinib Impurity 1（Alectinib M4 metabolite）;Alectinib M4;9-Ethyl-8-(4-(2-hydroxyethylamino)piperidin-1-yl)-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;5H-Benzo[b]carbazole-3-carbonitrile, 9-ethyl-6,11-dihydro-8-[4-[(2-hydroxyethyl)amino]-1-piperidinyl]-6,6-dimethyl-11-oxo-;Aletinib impurity 1 | | CAS: | 1256585-04-2 | | MF: | C28H32N4O2 | | MW: | 456.58 | | EINECS: | | | Product Categories: | | | Mol File: | 1256585-04-2.mol |  |
| | Alectinib M4 metabolite Chemical Properties |
| Melting point | >200°C | | Boiling point | 731.1±60.0 °C(Predicted) | | density | 1.29±0.1 g/cm3(Predicted) | | storage temp. | Refrigerator | | solubility | DMSO (Slightly), Methanol (Slightly, Heated) | | form | Solid | | pka | 13.70±0.40(Predicted) | | color | Off-White to Beige |
| | Alectinib M4 metabolite Usage And Synthesis |
| Uses | Alectinib M4 metabolite is the major active metabolite of Alectinib. Alectinib is an anaplastic lymphoma kinase (ALK) inhibitor and is used to treat non-small-cell lung cancer by blocking the activity of anaplastic lymphoma kinase (ALK). |
| | Alectinib M4 metabolite Preparation Products And Raw materials |
|